Drawing for SALIVASCAN

USPTO serial 88159237

SALIVASCAN

Reviewed by CopyMark Law Group

Reg. 5823398Status 702Registered
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
ELLIOTT, LASHAWNDA E
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SALIVASCAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Hoisington

Michael J. Hoisington Higgs Fletcher & Mack LLP401 West A StreetSuite 2600San Diego, CA 92101

Goods and services

ClassDescriptionStatusFirst use
005Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluidsACTIVENov 30, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 6, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 6, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 6, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 7, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jul 30, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 1, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 26, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 25, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 31, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 31, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 15, 2019IUAFUSE AMENDMENT FILED—
May 15, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 14, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 26, 2019DOCKASSIGNED TO EXAMINER—
Oct 29, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance